Dialysis graft system with self-sealing access ports

Details Dialysis graft system with self-sealing access ports Dialysis graft system with self-sealing access ports

1999-05-24

2001-07-17

McDermott, Corrine (Department: 3738)

Surgery

Devices transferring fluids from within one area of body to...

With flow control means

C604S175000, C623S001100

Reexamination Certificate

active

06261257

ABSTRACT:

FIELD OF INVENTION
The present invention relates generally to the field of dialysis grafts, and more specifically to a dialysis graft having self-sealing ports for repeated cannulation.
BACKGROUND OF THE INVENTION
Hemodialysis is now a commonly practiced method of treating patients suffering from renal failure. Hemodialysis machines serve to remove life-threatening chemicals from the blood stream, when the kidneys can no longer effectively remove such chemicals.
In order to perform hemodialysis, access must be obtained to the blood flow system, and blood flows of 150 to 400 ml/minute are required. Blood from veins is inadequate to meet these flow requirements, and repeated puncture of a large artery is not feasible.
Accordingly, a medical procedure has been developed whereby a fistula is created by surgically anastamosing a superficial artery and a nearby vein. The fistula is a surgical connection of an artery to a vein. When such a connection is created, the blood flow through the blood vessels involved is increased since the flow resistant capillaries are bypassed. The pressure at the venous side of the fistula is also increased, causing the vein to enlarge its diameter and causing the walls of the vein to thicken. Once these changes have taken place, the transformed vein becomes a site with a suitably large diameter and blood flow to puncture with needles for the purpose of connecting the patient to a dialysis machine.
If a native vein is not available for the anastomosis because the patient's blood vessels are not suitable for the formation of a fistula or the patient's blood vessels are not healthy enough for a fistula to be created, an artificial vessel or vascular graft is used to bridge an artery and a nearby vein. The material of the graft is suitable for puncturing with needles to achieve the necessary access to the patient's blood system.
These type of grafts are often connected between the distal radial artery and the cephalic or basilic vein. Each end of the fistula is anastomosed in an end-to-side fashion to the respective artery or vein. The most commonly used material to form prosthetic vascular grafts is expanded polytetrafluoroethylene (PTFE). And cannulation of arteriovenous fistulas or graft fistulas with 14-16 gauge needles permits blood flow sufficient to carry out hemodialysis.
The grafts are implanted entirely below the skin to reduce the risk of infection and to provide better comfort to the patient between dialysis treatments. A hypodermic needle is used to cannulate the vessel through the skin. During cannulation of the graft fistulas, direct punctures of the graft walls are made with the needles. One puncture is made in the graft wall in the arterial side and one puncture is made in the venous side. Repeated punctures of the graft material promote rupture of the graft, pseudoaneurysms, and the development of organized thrombus within the lumen of the graft. Organized thrombus may be the cause of graft thrombosis and eventual graft failure.
Repeated, direct punctures of the graft wall also require compression for hemostasis following the dialysis session. Excessive compression during hemostasis may cause decreased flow within the graft and thrombosis. Also, there is very little subcutaneous tissue between the surface of the skin and the graft wall reducing the capacity of extra luminal coagulation of the blood within the surrounding tissue and therefore causing reduced hemostasis at the end of the procedure.
What is needed is a dialysis access graft fistula that better provides for repeated cannulation while reducing the occurrence of ruptures of the graft, pseudoaneurysms, and the development of organized thrombus; and that reduces the problems discussed above with hemostasis.
SUMMARY OF THE INVENTION
The present invention meets the above-described needs by providing a graft that is particularly suitable for repeated dialysis. The graft provides a fistula between an artery and a vein and comprises a series of septums on both the arterial as well as the venous side. The septums are made of a stretchable material so that after puncture and withdrawal of the needle, the septum seals by itself. This avoids repeated puncture of the graft wall thereby prolonging the life of the graft. The development of the dialysis graft with puncture septums is a significant improvement over existing technology and can improve utilization by facilitating puncture and maintenance while reducing the risk of common complications such as pseudoaneurysms and thrombosis.


REFERENCES:
patent: 3826257 (1974-07-01), Buselmeier
patent: 4405319 (1983-09-01), Cosentino
patent: 4421507 (1983-12-01), Bokros
patent: 4496350 (1985-01-01), Cosentino
patent: 4512761 (1985-04-01), Raible
patent: 4559039 (1985-12-01), Ash et al.
patent: 4639247 (1987-01-01), Bokros
patent: 4822341 (1989-04-01), Colone
patent: 4897081 (1990-01-01), Poirier et al.
patent: 4898669 (1990-02-01), Tesio
patent: 4936826 (1990-06-01), Amarasinghe
patent: 5041098 (1991-08-01), Loiterman et al.
patent: 5192310 (1993-03-01), Herweck et al.
patent: 5421814 (1995-06-01), Geary
patent: 5443497 (1995-08-01), Venbrux
patent: 5520632 (1996-05-01), Leveen et al.
patent: 5647855 (1997-07-01), Trooskin
patent: 5704915 (1998-01-01), Melsky et al.
patent: 5728103 (1998-03-01), Picha et al.
patent: 5807356 (1998-09-01), Finch, Jr. et al.
patent: 5849036 (1998-12-01), Zarate
patent: 5876366 (1999-03-01), Dykstra et al.
patent: 5879320 (1999-03-01), Cazenave
Munda et al., “Polytetrafluoroethylene Graft Survival in Hemodialysis,” JAMA, Jan. 14, 1983, vol. 249, No. 2, pp. 219-222.
Anderson et al., “One Hundred Polytetrafluroethylene Vascular Access Grafts,” Dialysis & Transplantation, Mar. 1980, vol. 9, No. 3, pp. 237-238.
Palder, et al., “Vascular Access for Hemodialysis,” Ann. Surg., Aug. 1991, vol. 202, No. 2, pp. 235-239.
Levowitz et al., “Prosthetic Arteriovenous Fistula for Vascular Access in Hemodialysis,” The American Journal of Surgery, Sep. 1976, vol. 132, pp. 368-372.
Raju, “PTFE Grafts for Hemodialysis Access,” Ann. Surg. Nov. 1987, vol. 206, No. 5, pp. 666-673.
Volder et al., “A-V Shunts Created in New Ways,” Trans. Amer. Soc. Artif. Int. Organs, 1973, vol. XIX, pp. 38-42.
Kaplan et al., “Comparison of ‘PTFE’ and Bovine Grafts for Blood Access in Dialysis Patients,” Trans. Amer. Soc. Artif. Int. Organs, 1976, vol. XXII, pp. 388-393.
Rizzuti et al., “Extended Patency of Expanded Polytetrafluoroethylene Grafts for Vascular Access Using Optimal Configuration and Revisions,” Surgery, Gynecology & Obstetrics, Jan. 1988, vol. 166, pp. 23-27.
Baker et al., “Expanded Polytetrafluoroethylene (PTFE) Subcutaneous Arteriovenous Conduit: An Improved Vascular Access for Chronic Hemodialysis,” Trans. Amer. Soc. Artif. Int. Organs, 1976, vol. XXII, pp. 382-387.
Flores et al., “Dacron Arterio-Venous Shunts for Vascular Access in Hemodialysis, ”Trans. Amer. Soc. Artif. Int. Organs, 1973, vol. XIX, pp. 33-37.

Affiliated with

Also associated with

Rating

Dialysis graft system with self-sealing access ports does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dialysis graft system with self-sealing access ports, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dialysis graft system with self-sealing access ports will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2501615